Loading Search...
Robinhood vs Injective: A TradFi giant takes on a DeFi-native pioneer in the race to tokenize stocks. Here’s how both platforms compare—and what it means for the future of RWAs.
Author: Tanishq Bodh
The battle between Robinhood and Injective is heating up—this time in a new arena: onchain stocks.
While Injective has been quietly building a decentralized, high-speed tokenization platform for real-world assets (RWAs), Robinhood has now entered the chat—with regulatory muscle, brand power, and a bold vision.
But is this a threat to Injective or validation of its thesis?
Let’s unpack what both platforms are doing, how they stack up, and why this could be the next big frontier in crypto-finance convergence.
On June 30, 2025, Robinhood announced the launch of Robinhood Stock Tokens for EU customers, starting with over 200 tokenized U.S. stocks and ETFs, including access to private equity shares like OpenAI and SpaceX.
Robinhood is aiming to bridge the $30T equity market into crypto—without requiring users to understand complex DeFi tooling.
And the market responded fast: Robinhood’s stock surged 13% post-announcement.
While Robinhood is just stepping in, Injective has been live with tokenized stocks since early 2024—through its Helix platform, offering iAssets (Injective Assets) like $GOOGL, $TSLA, $CRCL, and even commodities and forex pairs.
Injective doesn’t just list stocks—it makes them composable across DeFi.
| Feature | Robinhood | Injective (Helix) |
|---|---|---|
| Audience | EU retail, TradFi crossover | DeFi-native, global |
| Trading Access | 24/5 | 24/7 |
| Assets | 200+ stocks, ETFs, private equity | Stocks, ETFs, commodities, forex |
| Tech Stack | Arbitrum L2 (native L2 soon) | Injective blockchain |
| Fees | Zero commission | Zero gas + market rebates |
| Custody | Semi-custodial (with future self-custody) | Fully non-custodial |
| Institutional Partners | Bitstamp, SEC proposal submitted | ETF managers, DeFi-native funds |
| Platform Maturity | Early-stage | Over a year of live traction |
| DeFi Integration | Planned | Live: lending, perps, yield strategies |
| UX/UI | Retail-focused | Pro-level; improving |
Robinhood’s arrival sends a clear message: tokenized stocks are real, and they’re coming fast.
Injective still holds powerful advantages:
But it must:
Robinhood vs Injective isn’t just a battle—it’s a reflection of where TradFi and DeFi collide.
Robinhood’s entry validates Injective’s vision, proving the world is finally catching up to what Helix has been quietly building for over a year.
In the short term, Robinhood might dominate headlines. But in the long term, Injective’s DeFi-native design could make it the platform that captures the full potential of programmable, interoperable, onchain finance.
The race is on. And it’s far from over.
